Thermo Fisher Scientific

Altoura Launches Immersive Training Platform for the Industrial Metaverse

Retrieved on: 
Tuesday, March 21, 2023
Maintenance, Senior, Software as a service, Building Engineering Services Association, Unity, 3D, Thermo Fisher Scientific, Software, Applied Materials, AI, Cummins, Environment, Rail transport, Management, Bridgestone, Wabtec, Ecolab

SEATTLE, March 21, 2023 /PRNewswire/ -- Altoura today announced the availability of Altoura 6, its next-generation immersive training platform for the industrial metaverse, as well as the Private Beta for its new AI services that automate and help scale training content development. Since its founding, Altoura has enabled companies to build frontline worker training for standard operating, maintenance, and safety procedures within a 3D environment. Altoura 6 now enables training creators to author powerful immersive simulations without writing code or using Unity for 3D asset management—and to access self-service analytics and generate reports to evaluate training performance and identify patterns that can be used to optimize training experiences.

Key Points: 
  • Altoura 6 empowers training teams to increase frontline worker productivity, improve worker safety, gain better insights into training performance, and dramatically lower training costs
    SEATTLE, March 21, 2023 /PRNewswire/ -- Altoura today announced the availability of Altoura 6, its next-generation immersive training platform for the industrial metaverse , as well as the Private Beta for its new AI services that automate and help scale training content development.
  • Since its founding, Altoura has enabled companies to build frontline worker training for standard operating, maintenance, and safety procedures within a 3D environment.
  • Altoura 6 now enables training creators to author powerful immersive simulations without writing code or using Unity for 3D asset management—and to access self-service analytics and generate reports to evaluate training performance and identify patterns that can be used to optimize training experiences.
  • The shift from legacy instructor-led training to immersive training enables industrial companies to do more with less.

Advanced Therapy Medicinal Products CDMO Market is expected to display a steady growth of 14% due to the rise in research & development activities | UnivDatos Market Insights

Retrieved on: 
Tuesday, March 21, 2023
SMA, Oncology, Advanced Therapy Medicinal Product, Central nervous system, Heart failure, Prevalence, Disability, Biotechnology, Stroke, COVID-19, Infection, Cancer, ATMP, Research, AGC, DSM-IV codes, Fujifilm, CDMO, Genetic disorder, Thermo Fisher Scientific, Cardiology, Education minister, Human musculoskeletal system, Conditional sentence, Growth, B cell, Catalent, Death, Gene therapy, Wuxi, Pharmaceutical industry, Health care, NOIDA

The advanced therapy medicinal products CDMO market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The advanced therapy medicinal products CDMO market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the advanced therapy medicinal products CDMO market.
  • The advanced therapy medicinal products CDMO market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the advanced therapy medicinal products CDMO market at the global and regional levels.

Advanced Therapy Medicinal Products CDMO Market is expected to display a steady growth of 14% due to the rise in research & development activities | UnivDatos Market Insights

Retrieved on: 
Tuesday, March 21, 2023
SMA, Oncology, Advanced Therapy Medicinal Product, Central nervous system, Heart failure, Prevalence, Disability, Biotechnology, Stroke, COVID-19, Infection, Cancer, ATMP, Research, AGC, DSM-IV codes, Fujifilm, CDMO, Genetic disorder, Thermo Fisher Scientific, Cardiology, Education minister, Human musculoskeletal system, Conditional sentence, Growth, B cell, Catalent, Death, Gene therapy, Wuxi, Pharmaceutical industry, Health care, NOIDA

The advanced therapy medicinal products CDMO market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The advanced therapy medicinal products CDMO market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the advanced therapy medicinal products CDMO market.
  • The advanced therapy medicinal products CDMO market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the advanced therapy medicinal products CDMO market at the global and regional levels.

World’s Leading Customer Data Platform Adobe Real-Time CDP Debuts Industry-First Innovations

Retrieved on: 
Tuesday, March 21, 2023
Data Management, Communications, Digital Marketing, Technology, Software, Electronic Commerce, Cloud, Sensei, Security Shield, Real Madrid CF, Habit, Meta, B2B, Face, Marketing, Coles, Partner, Truist Financial, TSB, LiveRamp, Data collection, Privacy, T. Rowe Price, Thermo Fisher Scientific, Adobe Experience Cloud, Amazon, Merkle, FC Bayern, Signet Jewelers, Novo Nordisk, ADBE, CDP, Growth, ServiceNow, Dow Chemical Company, Ecosystem, Suncorp Group, Petco, Conference, Major League Baseball, Panera Bread, Retail, Online shopping, Sales, Chipotle, Qualcomm, U.S. Bancorp, Adobe

Today, at Adobe Summit – the world’s largest Digital Experience Conference – Adobe (Nasdaq:ADBE) announced new innovations in Adobe Real-Time Customer Data Platform (Real-Time CDP), which now delivers over 600 billion predictive insights annually based on real-time customer profiles.

Key Points: 
  • Today, at Adobe Summit – the world’s largest Digital Experience Conference – Adobe (Nasdaq:ADBE) announced new innovations in Adobe Real-Time Customer Data Platform (Real-Time CDP), which now delivers over 600 billion predictive insights annually based on real-time customer profiles.
  • Powered by Adobe Experience Platform , Adobe Real-Time CDP insights enable teams to directly engage customers at key moments in their journeys.
  • “Adobe Experience Cloud applications, from Adobe Real-Time CDP to Adobe Journey Optimizer and Customer Journey Analytics, work together to help brands drive the next phase of their digital transformation, which will be anchored in wide-scale personalization,” said Anjul Bhambhri, senior vice president, Adobe Experience Cloud platform engineering at Adobe.
  • Managing consumer data responsibly: Adobe Real-Time CDP builds each new capability with privacy in mind, ensuring appropriate governance of every step from data ingestion to activation.

PhenomeX Strengthens Commercial Leadership Team

Retrieved on: 
Tuesday, March 21, 2023
DNA, Bachelor, Cell biology, Bachelor of Science, Therapy, Senior, Doctor of Philosophy, Workflow, Medical college, Microarray, Cancer, Life Technologies, Molecular Devices, Thermo Fisher Scientific, CCO, North West Regional Leaders Board, Patient, CELL, Medical College of Wisconsin, Siddhartha, Yan, Growth, Eurofins Scientific, Management, Science, Biochemistry, Peking University, Affymetrix

EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that Yan Zhang, Ph.D., has been named chief commercial officer (CCO), effective immediately. In addition to Dr. Zhang's appointment, PhenomeX also announced that Tomoya Aoyama has been named Regional Leader, overseeing the Company's commercial operations in APAC.

Key Points: 
  • In addition to Dr. Zhang's appointment, PhenomeX also announced that Tomoya Aoyama has been named Regional Leader, overseeing the Company's commercial operations in APAC.
  • With the combination of Berkeley Lights and IsoPlexis complete to form PhenomeX, Dr. Zhang will oversee a significantly expanded commercial organization with an enhanced geographical footprint.
  • "We are incredibly excited to welcome Dr. Zhang to PhenomeX, further strengthening our talented leadership team," said Siddhartha Kadia, Ph.D., chief executive officer of PhenomeX.
  • "I am thrilled to welcome Aoyama-san to the growing regional commercial teams at PhenomeX," concluded Dr. Kadia.

Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market

Retrieved on: 
Tuesday, March 21, 2023
Packaging, Medical Supplies, Health, Manufacturing, General Health, Pharmaceutical, Drug development, Biotechnology, Multimedia, Thermo Fisher Scientific, Vaccine, Science, Patient, Stevanato Group, Administration, NYSE, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20230321005240/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230321005240/en/
    Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market (Photo: Business Wire)
    The semi-reusable drug delivery device will provide micro-precision basal doses and full-content bolus injections as a highly flexible and customizable platform for administering a wide range of therapies.
  • “We are proud to be working with Thermo Fisher Scientific to bring to the market our on-body delivery system for patients,” said Steven Kaufman, VP for Drug Delivery Systems at Stevanato Group.
  • The on-body delivery system increases the accessibility of in-home care and administered treatment options.”
    The development of the on-body delivery system is also a step forward for Stevanato Group’s sustainability efforts.
  • “In line with our mission to enable our customers to make the world healthier, cleaner and safer, we’ll significantly improve patients’ access and adherence to critical medicines.”
    For more information on Stevanato Group’s proprietary on-body delivery system, visit: On-Body Delivery System - Stevanato Group

PHARMACEUTICS INTERNATIONAL ONBOARDS NEW LEADERSHIP TEAM TO DRIVE QUALITY, OPERATIONAL IMPROVEMENTS, AND GROWTH

Retrieved on: 
Monday, March 20, 2023
Online, Vaccine, GMP, Human resources, AstraZeneca, Employment, General counsel, Asepsis, Culture, Head, Business operations, EVP, Abbott Laboratories, ISO, Valley, Business, Risk management, Olympus, PII, Thermo Fisher Scientific, Catalent, History, Assistant, Colorado Technical University, CDMO, Acquisition, Project management, Patient, Supply chain, HUNT, Getinge, ICU Medical, CFO, Supply, Grand River Aseptic Manufacturing, Indoxacarb, Management, Fine chemical, Pharmaceutical industry, MD, Sanofi

For over twenty-five years, the company has been providing technical and regulatory capabilities and Pharmaceutics Know-How™.

Key Points: 
  • For over twenty-five years, the company has been providing technical and regulatory capabilities and Pharmaceutics Know-How™.
  • Under Fowlers’ leadership, Pii will focus on the highest level of customer service.
  • Supporting Devan in his expanded role is Sara Frederick, who has joined Pii as Senior Director of Business Operations.
  • He has worked in many HR leadership roles in the medical technology space including Olympus and Thermo Fisher Scientific.

Genetic Testing Market to Reach $28.24 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

Retrieved on: 
Monday, March 20, 2023
Glaucoma, DNA, Ventricular septal defect, Prevalence, Impact, Viral Research and Diagnostic Laboratories, Parent, Hospital, Pharmacogenomics, COVID-19, Cancer, Down syndrome, Genetic testing, Diagnosis, Genomics, Hemoglobinopathy, Disorder, Government, PerkinElmer, Fragile X syndrome, MUFG Americas Holdings Corporation, Thermo Fisher Scientific, Patient, Laboratory, Risk, Developed country, Preimplantation genetic diagnosis, Investment, Labcorp, Consumables, Cystic fibrosis, Carrier, Hospital Clinic Manuel Quintela, Association for Molecular Pathology v. Myriad Genetics, Inc., Rare, Illumina, Inc., Geography, Pharmaceutical industry, Dietary supplement, Chromosome, Prenatal development

Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.

Key Points: 
  • Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.
  • Genetic testing is performed for different reasons, including pre-symptomatic and predictive testing, pharmacogenetics, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, and newborn screening.
  • Genetic testing has applications in different areas of healthcare and has various advantages, such as determining the likelihood of parents passing the genetic mutation to their offspring.
  • Quick Buy – Genetic Testing Market Research Report: https://www.meticulousresearch.com/Checkout/33822956
    Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of this market.

Genetic Testing Market to Reach $28.24 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

Retrieved on: 
Monday, March 20, 2023
Glaucoma, DNA, Ventricular septal defect, Prevalence, Impact, Viral Research and Diagnostic Laboratories, Parent, Hospital, Pharmacogenomics, COVID-19, Cancer, Down syndrome, Genetic testing, Diagnosis, Genomics, Hemoglobinopathy, Disorder, Government, PerkinElmer, Fragile X syndrome, MUFG Americas Holdings Corporation, Thermo Fisher Scientific, Patient, Laboratory, Risk, Developed country, Preimplantation genetic diagnosis, Investment, Labcorp, Consumables, Cystic fibrosis, Carrier, Hospital Clinic Manuel Quintela, Association for Molecular Pathology v. Myriad Genetics, Inc., Rare, Illumina, Inc., Geography, Pharmaceutical industry, Dietary supplement, Chromosome, Prenatal development

Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.

Key Points: 
  • Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.
  • Genetic testing is performed for different reasons, including pre-symptomatic and predictive testing, pharmacogenetics, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, and newborn screening.
  • Genetic testing has applications in different areas of healthcare and has various advantages, such as determining the likelihood of parents passing the genetic mutation to their offspring.
  • Quick Buy – Genetic Testing Market Research Report: https://www.meticulousresearch.com/Checkout/33822956
    Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of this market.

China Biological Reagents Market Report 2023 to 2027: Players Include Thermo Fisher Scientific, Qiagen, PerkinElmer and Danaher - ResearchAndMarkets.com

Retrieved on: 
Monday, March 20, 2023
Health, Biotechnology, Vaccine, Molecular biology, COVID-19, Research, DSM-IV codes, COVID, Danaher Corporation, Government, Incidence, PerkinElmer, Protein, Thermo Fisher Scientific, Mindful Scientific Inc., Gene, Growth

The China biological reagent market by category can be segmented as follows: molecular biology reagents, proteins and cell reagents.

Key Points: 
  • The China biological reagent market by category can be segmented as follows: molecular biology reagents, proteins and cell reagents.
  • In 2022, the dominant share of China biological reagent market was held by molecular biology reagents, followed by proteins and cell reagents.
  • The China biological reagents market was positively affected due to increased demand for biological reagents.
  • The report provides a comprehensive analysis of the China biological reagent market with potential impact of COVID-19.